Species: Veillonella rogosae (HMT-0158) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0158: [Body Sites Data]
[Taxon Description]
| Life Page: Veillonella rogosae
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.12 | 0.16 | 0.08 | 0.22 | 0.59 | 0.90 | 1.84 | 1.93 | 3.07 | 3.26 | 0.22 | 0.02 | 0 | 0.36 | 0 | 0.02 | 0.08 | 0.03 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.04 | 0.02 | 0.01 | 0.01 | 0.08 | 0.90 | 1.25 | 0.87 | 0.30 | 1.18 | 0 | 0 | 0 | 0.36 | 0 | 0 | 0 | 0 |
| 90thp | 0.22 | 0.29 | 0.19 | 0.56 | 1.24 | 0.90 | 2.64 | 3.03 | 9.10 | 6.35 | 0.15 | 0.04 | 0.01 | 0.36 | 0 | 0.05 | 0.03 | 0.03 |
| Stdev | 0.08 | 0.41 | 0.13 | 0.30 | 0.72 | 0 | 0.61 | 0.98 | 3.46 | 2.31 | 1.04 | 0.03 | 0.01 | 0 | 0 | 0.04 | 0.65 | 0.20 |
| Prev(%) | 25.00 | 50.13 | 0 | 40.00 | 72.45 | 100.00 | 100.00 | 100.00 | 86.36 | 99.76 | 3.08 | 0 | 0 | 0 | 0 | 12.50 | 1.06 | 5.33 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.02 | 0.02 | 0.17 | 0.70 | 1.92 | 3.01 | 1.71 | 2.70 | 3.05 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.23 | 0.20 | 0.03 | 0.05 | 0.05 | 0 |
| 90thp | 0.06 | 0.06 | 0.43 | 1.59 | 4.47 | 6.87 | 4.74 | 7.13 | 7.36 | 0.01 |
| Stdev | 0.05 | 0.05 | 0.32 | 0.97 | 2.01 | 2.89 | 2.58 | 3.42 | 3.33 | 0.02 |
| Prev(%) | 31.17 | 35.06 | 66.23 | 88.31 | 94.81 | 93.51 | 92.21 | 90.91 | 94.81 | 11.69 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.80 | 0.75 | 0.28 | 0.57 | 1.17 | 2.32 | 1.55 | 1.41 | 2.01 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.07 | 0.08 | 0 | 0.08 | 0.32 | 0.87 | 0.55 | 0.46 | 0.81 | 0 |
| 90thp | 2.05 | 1.71 | 0.78 | 1.40 | 2.31 | 3.92 | 2.69 | 2.61 | 3.27 | 0.01 |
| Stdev | 1.11 | 0.86 | 0.59 | 0.56 | 0.78 | 1.19 | 0.85 | 0.87 | 0.97 | 0.04 |
| Prev(%) | 98.65 | 100.00 | 91.22 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 29.37 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-158 and HMT-160 were assigned to each taxon in proportion to the abundance of HMT-158 and HMT-160 individually at these sites (AKE,BMU,HPA,LAF,PTO,SAL,THR,TDO).
Reads equidistant to HMT-158 and HMT-160 were assigned to each taxon in proportion to the abundance of HMT-158 and HMT-160 individually at these sites (AKE,BMU,HPA,LAF,PTO,SAL,THR,TDO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.02 | 0 | 0.21 | 0.79 | 1.91 | 2.43 | 1.80 | 2.46 | 2.74 | 0.05 | 0.05 | 0.02 | 0.08 | 0.13 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.01 | 0.20 | 0.20 | 0.03 | 0.06 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.05 | 0 | 0.54 | 2.19 | 4.33 | 5.66 | 4.95 | 6.26 | 7.31 | 0.09 | 0.03 | 0.03 | 0.20 | 0.25 | 0 | 0 | 0 | 0 |
| Stdev | 0.07 | 0 | 0.33 | 0.99 | 2.07 | 2.37 | 2.57 | 3.44 | 3.28 | 0.24 | 0.43 | 0.11 | 0.28 | 0.74 | 0 | 0 | 0 | 0 |
| Prev(%) | 50.33 | 0 | 76.92 | 92.47 | 97.99 | 94.61 | 94.34 | 96.67 | 96.77 | 31.00 | 18.68 | 18.98 | 26.44 | 22.58 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.04 | 0.36 | 1.14 | 3.40 | 3.04 | 2.06 | 2.71 | 3.33 | 0.18 | 0.17 | 0.25 | 0.31 | 0.53 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.25 | 0.28 | 0.04 | 0.08 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.08 | 0.94 | 2.86 | 8.07 | 6.34 | 5.89 | 7.42 | 8.78 | 0.49 | 0.12 | 0.28 | 0.56 | 1.63 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0.19 | 0.83 | 1.67 | 3.26 | 2.93 | 2.93 | 3.44 | 3.74 | 0.49 | 0.77 | 1.15 | 1.11 | 1.52 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 45.85 | 66.67 | 88.83 | 96.42 | 98.21 | 93.46 | 97.08 | 97.57 | 53.26 | 28.02 | 33.33 | 38.62 | 50.67 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
Notes:
Reads equally close to HMT 158, 160, and 161 were distributed equally among taxa.
Reads equally close to HMT 158, 160, and 161 were distributed equally among taxa.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.02 | 0.04 | 0.51 | 0.85 | 1.20 | 1.08 | 1.64 | 1.04 | 1.48 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.01 | 0.12 | 0.03 | 0.08 | 0.02 | 0.01 | 0 |
| 90thp | 0.04 | 0.11 | 1.76 | 2.22 | 2.97 | 2.31 | 3.17 | 2.45 | 3.62 | 0 |
| Stdev | 0.03 | 0.09 | 0.83 | 1.11 | 1.55 | 0.87 | 4.07 | 1.63 | 1.82 | 0.02 |
| Prev(%) | 78.38 | 91.18 | 97.67 | 100.00 | 100.00 | 98.00 | 100.00 | 96.77 | 100.00 | 5.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.01 | 0.07 | 0 | 0.17 | 1.00 | 1.36 | 2.15 | 1.57 | 3.24 | 3.67 | 0.12 | 0 | 0 | 0.07 | 0 | 0 | 0.06 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 1.36 | 0.51 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 |
| 90thp | 0.01 | 0.07 | 0 | 0.38 | 2.69 | 1.36 | 4.13 | 3.17 | 12.10 | 9.87 | 0 | 0 | 0 | 0.07 | 0 | 0 | 0 | 0 |
| Stdev | 0.04 | 0.58 | 0 | 0.45 | 1.64 | 0 | 1.66 | 3.31 | 5.04 | 4.28 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0.65 | 0.09 |
| Prev(%) | 12.50 | 42.17 | 0 | 41.18 | 88.83 | 100.00 | 87.50 | 68.75 | 80.00 | 94.37 | 5.86 | 4.17 | 0 | 100.00 | 0 | 7.14 | 1.01 | 9.46 |

